Drug discovery and development in four Canadian biotech companies

Authors: Tapon, Francis¹; Thong, Mona²; Bartell, Marvin³

Source: R&D Management, Volume 31, Number 1, January 2001 , pp. 77-90(14)

Buy & download fulltext article:

Price: $48.00 plus tax (Refund Policy)

Abstract:

In this paper, we discuss the R&D process in the pharmaceutical/biotechnology industry from the viewpoint of four leading Canadian biotech startups. Based on a series of interviews with these firms, we outline the role of joint ventures and strategic alliances with university laboratories and with large established pharmaceutical firms in furthering these small firms' ambition of themselves becoming large and established. We find that the evolution of this industry has made this goal much harder to reach and we discuss the creative ways in which these firms have adapted and thrived.

Document Type: Original article

DOI: http://dx.doi.org/10.1111/1467-9310.00198

Affiliations: 1: Department of Economics, University of Guelph, Guelph, Ontario, Cananda, 2: Department of Management Sciences, University of Waterloo, Waterloo, Ontario, Canada, 3: Faculty of Management, University of Manitoba, Winnipeg, MB, Canada

Publication date: 2001-01-01